{"schema_version":"secwatch.filing_event.v1","accession":"0000898432-22-000631","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2022-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.136228+00:00","generated_at":"2026-06-22T08:19:43.620486+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"iRadimed Q3 revenue up 23% to $13.4M; GAAP EPS $0.27; guides Q4 rev $14.1-14.8M","bullets":["Q3 revenue $13.4M (+23% YoY), operating income $4.1M (+32%), GAAP EPS $0.27 (+35%).","Non-GAAP net income $3.7M (excl. $0.3M stock comp); nine-month non-GAAP EPS $0.78 vs $0.50.","Gross margin improved to 78.6% from 77.1%; operating cash flow $3.9M in Q3.","Q4 guidance: revenue $14.1-14.8M, GAAP EPS $0.23-0.28, non-GAAP EPS $0.25-0.30.","CEO cites strong bookings and backlog; purchased 27 acres in Orlando for future HQ, tripling space."],"urls":{"canonical":"https://secwatch.observer/filing/0000898432-22-000631","json":"https://secwatch.observer/filing/0000898432-22-000631.json","markdown":"https://secwatch.observer/filing/0000898432-22-000631.md","text":"https://secwatch.observer/filing/0000898432-22-000631.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000089843222000631/0000898432-22-000631-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000089843222000631/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T08:19:43.620486+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"14774629816a0897d6e3c17d192e16c8afefb9e9","claim":"IRADIMED CORP reported financial results for the third quarter ended September 30, 2022.","evidence_excerpt":"On November 3, 2022, iRadimed Corporation issued a press release (the “Press Release”) announcing its financial results for the third quarter ended September 30, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000089843222000631/0000898432-22-000631-index.htm","confidence":0.7,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the third quarter ended September 30, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}